NCT00597961|CompletedDMC
Loading search results
Sponsor study identifier
observational
42
1 country
1
Study Start
August 12, 2003
Actual (reported)Primary Completion
April 14, 2020
Actual (reported)Study Completion
April 14, 2020
Actual (reported)There are two goals of this research study. First, we hope to develop a plan to guide family discussions that can help parents diagnosed with lung cancer talk about cancer risk with their adult children. Second, we want to understand how families talk about cancer prevention.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 14, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 12, 2003
Actual (reported)January 9, 2008
Actual (reported)January 18, 2008
Actual (reported)April 14, 2020
Actual (reported)April 14, 2020
Actual (reported)We will use data from our qualitative interviews to develop a family-focused assessment battery for examining risk perception and risk communication in families affected by cancer.
7 years
Concentrating on two distinct tumor types, lung cancer and melanoma, because of the prominence of risk behaviors in the etiology of both of these cancers. With regard to lung cancer, we have identified high concordance of smoking among the spouses, siblings and children of recently diagnosed patients. In the context of melanoma, patients report a desire to use focused family discussions to encourage family members to reduce their skin cancer risk and increase early detection behaviors. "Family" defined as a group consisting of blood relatives, domestic partners, \& on-blood relatives as defined by cancer patient. During interviews with melanoma-affected families we will be gathering data from a melanoma patient \& ne of their adult sons or daughters. During the interviews with lung cancer-affected families we will be gathering data from a lung cancer patient and either one of their adult children, or one of their siblings, or their spouse.
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Jamie Ostroff, PhD
Memorial Sloan Kettering Cancer Center
42 participants (actual enrollment reported by the registry).
First Submitted
January 9, 2008
First Posted
January 18, 2008
Study Start
August 12, 2003
Actual (reported)Study of Talabostat and Cisplatin in Advanced Melanoma
Contact the study team to confirm eligibility.
Primary Completion
April 14, 2020
Actual (reported)Study Completion
April 14, 2020
Actual (reported)Last Updated
April 16, 2020
Record last verified: 2020-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: